Ibogaine: An Update
Zenodo (CERN European Organization for Nuclear Research) January 1, 2023 Sameš, Dalibor
Ibogaine, a psychoactive alkaloid, is being investigated for its potential to treat substance use disorders. The abstract reports an update on ibogaine presented at a 2023 conference in Prague, but provides no specific findings, data, or conclusions about its efficacy or mechanisms.